Player FM - Internet Radio Done Right
0-10 subscribers
Checked 16h ago
Додано four роки тому
Вміст надано jruss88 and Vox Markets Podcast. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією jruss88 and Vox Markets Podcast або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !
Переходьте в офлайн за допомогою програми Player FM !
2025: Addressing the Rising Threat of Whooping Cough
Manage episode 463388441 series 2936804
Вміст надано jruss88 and Vox Markets Podcast. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією jruss88 and Vox Markets Podcast або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Watch on YouTube
In an exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest milestone—a world-first pivotal Phase 3 human challenge trial for a whooping cough (pertussis) vaccine candidate. Mo delves into why ILiAD is leading this groundbreaking initiative, the trial’s key objectives, and its significance for hVIVO’s expanding portfolio. He also provides insight into the increasing global burden of pertussis and hVIVO’s readiness to conduct bacterial challenge trials at its state-of-the-art Canary Wharf facility.
In an exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest milestone—a world-first pivotal Phase 3 human challenge trial for a whooping cough (pertussis) vaccine candidate. Mo delves into why ILiAD is leading this groundbreaking initiative, the trial’s key objectives, and its significance for hVIVO’s expanding portfolio. He also provides insight into the increasing global burden of pertussis and hVIVO’s readiness to conduct bacterial challenge trials at its state-of-the-art Canary Wharf facility.
2077 епізодів
Manage episode 463388441 series 2936804
Вміст надано jruss88 and Vox Markets Podcast. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією jruss88 and Vox Markets Podcast або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Watch on YouTube
In an exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest milestone—a world-first pivotal Phase 3 human challenge trial for a whooping cough (pertussis) vaccine candidate. Mo delves into why ILiAD is leading this groundbreaking initiative, the trial’s key objectives, and its significance for hVIVO’s expanding portfolio. He also provides insight into the increasing global burden of pertussis and hVIVO’s readiness to conduct bacterial challenge trials at its state-of-the-art Canary Wharf facility.
In an exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest milestone—a world-first pivotal Phase 3 human challenge trial for a whooping cough (pertussis) vaccine candidate. Mo delves into why ILiAD is leading this groundbreaking initiative, the trial’s key objectives, and its significance for hVIVO’s expanding portfolio. He also provides insight into the increasing global burden of pertussis and hVIVO’s readiness to conduct bacterial challenge trials at its state-of-the-art Canary Wharf facility.
2077 епізодів
Усі епізоди
×
1 2045: Small-Cap Investing with Paul Hill & Paul Scott 1:10:16
1:10:16
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:10:16
Watch on YouTube In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts on the following: 00:00 Recent buys & sells and YTD performance of 2025 top 20 portfolio 02:30 Beeks Financial 07:10 JET2 10:30 Wilmington 16:20 Tracsis 21:10 Springfield Properties 25:55 Intercede 28:20 Zytronic 30:55 FRP Advisory and Begbies Traynor 33:30 Microcap investment trusts and #MAPL 36:00 CREO Medical 39:35 Assetco 41:25 Journeo 44:55 Everplay (formerly Team 17) 46:10 MONY (formerly Moneysupermarket) 49:15 ECO Animal Health 53:15 Zoo Digital 56:50 Videndum 1:00:10 Facilities of ADF 1:03:05 ITV and Zinc Media #BKS #JET2 #TRCS #SPR #IGP #ZYT #FRP #BEG #MAPL #CREO #ASTO #JNEO #EVPL #MONY #EAH #ZOO #VID #ADF #ZIN #ITV…
CleanTech Lithium's shares are looking cheap, following a period of lithium price decline, which makes the recently announced retail offer of shares and warrants look attractively priced. Executive chairman Steve Kesler joins us to tell us why he thinks the lithium price may at last be on the road to recovery.…

1 2043: The Exchange with Brendan Gulston of Gresham House 1:08:48
1:08:48
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:08:48
Watch on YouTube In this investing masterclass, accomplished UK fund manager Brendan Gulston of Gresham House takes me through his view of the markets and latest thoughts on 18 stock ideas, including: 00:00 Equity outlook 03:15 MPAC 06:30 ActiveOps 10:40 Windward 12:35 Argentex 18:50 Iomart 23:05 SysGroup 26:25 XPS Pensions 29:10 CVS Group & Pets-at-home 31:55 Nichols 36:40 Greggs 41:10 Ten Lifestyle 45:00 Angling Direct 47:50 IXICO 52:05 Fintel 54:10 Trufin 59:05 UK civil contractors & Costain 1:03:35 Favourite stock idea for 2025. Diaceutics…
Watch on YouTube We sat down with Mo Khan, CEO of hVIVO #HVO, to discuss their latest £2 million contract and what it means for the future of hMPV research. With a successful pilot study already completed, hVIVO is now gearing up for the final stage of its hMPV characterisation study, paving the way for future human challenge trials.…

1 2042: Small-Cap Investing with Paul Hill & Paul Scott 1:14:49
1:14:49
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:14:49
Watch on YouTube In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts on the following: 00:00 Equity outlook 06:20 Iomart 07:05 Tracsis 09:40 Housebuilders, Bellway & MJ Gleeson 14:25 Pinewood 18:30 Ricardo 21:25 Vertu Motors 22:30 Wynnstay 25:00 ONDO Insurtech 34:25 MS International & defence sector 38:40 hVivo 41:15 Focusright 45:25 Portfolio position sizing 50:25 Warpaint 51:50 Favourite sector 52:50 Gattaca 56:15 Speedy Hire 59:00 Close Brothers , S&U and Secure Trust Bank 64:10 PZ Cussons 65:30 Dunelm 68:40 Wood Group 70:20 First Group…
Watch on YouTube CleanTech Lithium #CTL has raised £2.4 million to take it on to the next steps with its Laguna Verde project. Chairman Steve Kesler tells us who's come in with the new money, and what the next couple of months will look like

1 2040: Mining Matters: Golden Prospect talks gold 1:31:13
1:31:13
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:31:13
Watch on YouTube Whither goest gold? Keith Watson and Robert Crayfourd of Golden Prospect Precious Metals talk gold, gold equities, investment strategies, ETFs, risk, Trump and the macro-economic outlook. The bottom line? - gold is the place to be.
Watch on YouTube In this investing masterclass, accomplished UK fund manager Gervais Williams of Premier Miton takes me through his view of the markets and latest thoughts on 25 stock ideas, including: 00:00 Edison Research, Filtronic & 2025 equity outlook 05:25 Yu Group 07:50 Beeks Financial Cloud 10:10 Van Elle 10:35 Galliford Try 12:30 Shoe Zone 14:20 Supreme 17:20 Avacta 18:25 Eleco 20:05 Guardian Metal Resources 23:05 Serabi Gold 26:15 CMC Markets 29:15 Kromek 32:15 Inspiration Healthcare 34:25 Zotefoams 36:50 Ashtead Technology 37:30 TP ICAP 39:30 Concurrent Technologies 42:00 CML Microsystems 44:10 Windar Photonics 47:25 Ondo InsurTech 50:20 Velocity Composites 52:20 Cavendish Financial 53:45 Other interesting firms – Virgin Wines , Shield Therapeutics & Firering Strategic Minerals #FTC #YU #BKS #CAV #CML #CNC #ELCO #GMET #ONDO #SHOE #SRB #SUP #VEL #WPHO #ZTF #CMCX #AT. #AVCT #GFRD #KMK #IHC #TCAP #VANL #FRG #VINO #STX #FRG…

1 2038: Small-Cap Investing with Paul Hill & Paul Scott 1:07:09
1:07:09
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:07:09
Watch on YouTube In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts on the following: 00:00 Equity outlook 05:20 Warpaint 11:10 Vertu Motors 14:00 Iomart 19:45 Filtronic 23:50 Alumasc 28:05 JD Sports 30:40 Victorian Plumbing 34:05 Optima Health 38:45 Assetco 41:40 Grainger 45:45 Gattaca & UK recruiters 50:50 Funding Circle 55:25 Ten Lifestyle 1:00:35 Cohort 1:02:30 HAT 1:05:05 Eurocell #W7L #VTU #IOM #FTC #ALU #JD. #VIC #OPT #ASTO #GRI #GATC #FCH #TENG #CHRT #HAT #ECL…

1 2037: Mining Matters: Bob Archer on silver, gold, markets, and Pinnacle 1:17:30
1:17:30
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:17:30
Watch on YouTube Silver vs gold vs markets. Bob Archer has decades of experience mining silver and gold, and knows the market dynamics of both metals better than most. He shares the insights he's gleaned over the years, and tells us about a new Mexican deal he's putting together inside Venture-listed Pinnacle Silver & Gold…
Watch on YouTube In this exclusive interview Chris, CEO of Polarean , discusses the company’s latest achievements

1 2035: The Exchange with Stephen English of Stellar Asset Management 1:22:58
1:22:58
Відтворити Пізніше
Відтворити Пізніше
Списки
Подобається
Подобається1:22:58
In this investing masterclass, accomplished UK fund manager Stephen English of Stellar Asset Management takes me through his view of the markets and latest thoughts on 14 stock ideas
Watch on YouTube Pulsar Helium #PLSR has completed drilling at its Jetstream #2 well, and encountered significant helium thicknesses and attractive grades. The results correlate well with those obtained from the recently re-drilled Jetstream #1 well. We are joined by Pulsar chief executive Thomas Abraham-James to tell us more.…
Watch on YouTube Following today’s positive FY'24 trading update, CEO Jerry Randall of Venture Life - a leading consumer healthcare products firm - kindly take me through the company's: Current demand picture & FY’24 performance. Strategic rationale & integration of Nov’s £10m acquisition of Health & Her Outlook for 2025 and beyond.…
In this exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest human challenge trial contract with Inhalon Biopharma, testing a next-generation mucosal RSV antiviral. Mo addresses industry speculation around RSV trials, explains why RSV antivirals remain a key growth area, and shares insights on hVIVO’s strong sales pipeline conversion, with this being their fourth new study announcement in under two months. He also provides a quick update on the recent CRS acquisition and what’s next for the company.…
Ласкаво просимо до Player FM!
Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.